 |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for SHCBP1L |
 Gene summary |
| Basic gene information | Gene symbol | SHCBP1L |
| Gene name | SHC SH2-domain binding protein 1-like | |
| Synonyms | C1orf14|GE36 | |
| Cytomap | UCSC genome browser: 1q25.3 | |
| Type of gene | protein-coding | |
| RefGenes | NM_030933.2, | |
| Description | GE36SHC SH2 domain-binding protein 1-like protein | |
| Modification date | 20141207 | |
| dbXrefs | HGNC : HGNC | |
| Ensembl : ENSG00000157060 | ||
| HPRD : 16634 | ||
| Vega : OTTHUMG00000035419 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_SHCBP1L | |
| BioGPS: 81626 | ||
| Pathway | NCI Pathway Interaction Database: SHCBP1L | |
| KEGG: SHCBP1L | ||
| REACTOME: SHCBP1L | ||
| Pathway Commons: SHCBP1L | ||
| Context | iHOP: SHCBP1L | |
| ligand binding site mutation search in PubMed: SHCBP1L | ||
| UCL Cancer Institute: SHCBP1L | ||
| Assigned class in TissGDB* | B | |
| Included tissue-specific gene expression resources | HPA,TiGER,GTEx | |
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
| Reference showing the relevant tissue of SHCBP1L | ||
| Description by TissGene annotations | ||
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID |
| Top |
| TissGeneExp for SHCBP1L |
| Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
| Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
 |
| Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
 |
| Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| Top |
| TissGene-miRNA for SHCBP1L |
| Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| Top |
| TissGeneMut for SHCBP1L |
| TissGeneSNV for SHCBP1L |
| nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
 |
| Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
 |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.M635I | SKCM | 2 |
| p.L68M | ACC | 2 |
| p.G374E | SKCM | 2 |
| p.G494V | COAD | 1 |
| p.M352I | GBM | 1 |
| p.R376* | GBM | 1 |
| p.H549N | UCEC | 1 |
| p.R314C | UCEC | 1 |
| p.A574S | PAAD | 1 |
| p.A531D | ESCA | 1 |
| p.G241R | SKCM | 1 |
| p.N581S | BLCA | 1 |
| p.E316K | READ | 1 |
| p.D245V | ESCA | 1 |
| p.D80Y | LUAD | 1 |
| p.R197H | UCEC | 1 |
| p.A531T | STAD | 1 |
| p.V604I | READ | 1 |
| p.E547K | SKCM | 1 |
| p.E452Q | HNSC | 1 |
| p.E129K | UCEC | 1 |
| p.A103T | STAD | 1 |
| p.E377* | UCEC | 1 |
| p.G566R | SKCM | 1 |
| p.G616E | SKCM | 1 |
| p.S209F | SKCM | 1 |
| p.L263V | CESC | 1 |
| p.W337X | SKCM | 1 |
| p.L317F | SKCM | 1 |
| p.A89E | DLBC | 1 |
| p.E101D | BLCA | 1 |
| p.E226K | SKCM | 1 |
| p.R371H | COAD | 1 |
| p.R371H | HNSC | 1 |
| p.D133G | SKCM | 1 |
| p.E91G | LIHC | 1 |
| p.L183F | LIHC | 1 |
| p.E316K | SKCM | 1 |
| p.E254K | SKCM | 1 |
| p.W337* | SKCM | 1 |
| p.D620N | BLCA | 1 |
| p.T392N | KIRP | 1 |
| p.E222K | HNSC | 1 |
| p.C511Y | CESC | 1 |
| p.K305T | BLCA | 1 |
| p.R217K | BLCA | 1 |
| p.A11V | STAD | 1 |
| p.G591V | UCEC | 1 |
| p.Y191C | LUSC | 1 |
| p.A44S | PRAD | 1 |
| p.Q529* | SKCM | 1 |
| p.A432D | LUAD | 1 |
| p.H476Y | HNSC | 1 |
| p.G144D | BLCA | 1 |
| p.A84E | LIHC | 1 |
| p.E129K | COAD | 1 |
| p.R357H | STAD | 1 |
| p.N637T | UCEC | 1 |
| p.S5F | PAAD | 1 |
| p.V604I | STAD | 1 |
| p.R283I | COAD | 1 |
| p.E506K | LIHC | 1 |
| p.E316K | STAD | 1 |
| p.E254K | LUAD | 1 |
| p.A300T | UCEC | 1 |
| p.S457C | LUAD | 1 |
| p.N416T | SKCM | 1 |
| p.A11T | STAD | 1 |
| p.Q291K | SARC | 1 |
| p.E452K | SKCM | 1 |
| p.G428E | SKCM | 1 |
| p.A103V | UCEC | 1 |
| p.I318M | KIRC | 1 |
| p.E271D | SKCM | 1 |
| p.V447A | UCEC | 1 |
| p.P427S | SKCM | 1 |
| p.A85V | SKCM | 1 |
| Top |
| TissGeneCNV for SHCBP1L |
| Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
 |
| Top |
| TissGeneFusions for SHCBP1L |
| Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Top |
| TissGeneNet for SHCBP1L |
| Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| Top |
| TissGeneProg for SHCBP1L |
| Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
| Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
| Top |
| TissGeneClin for SHCBP1L |
| TissGeneDrug for SHCBP1L |
| Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for SHCBP1L |
| Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
Copyright 2016-Present - The University of Texas Health Science Center at Houston (UTHealth) Web File Viewing | How to Report, Fraud, Waste and Abuse | State of Texas | Statewide Search | Texas Homeland Security | Site Policies |